Intracranial Efficacy of Afatinib as First-line Treatment in Common/Uncommon EGFR-Mutant Advanced Non-small Cell Lung Cancer Patients

被引：0

作者：

Liang, Y. ^{[1
]}

Kang, L. ^{[1
]}

Lin, Y. ^{[2
]}

Mai, J. ^{[1
]}

Zou, Q. ^{[1
]}

Huang, C. ^{[3
,4
]}

机构：

[1] Sun Yat Sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China

[2] Sun Yat Sen Univ, Dept Thorac Surg, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China

[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Med Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Shenzhen, Peoples R China

[4] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen, Peoples R China

来源：

关键词：

brain metastases; afatinib; EGFR mutation;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.09-31

引用

页码：S345 / S346

页数：2